Study of Metabolic Associated Fatty Liver Disease in Adults With Type 2 Diabetes in Jiangsu Province, China A Real-World, Multicenter, 5-Year Follow-Up Study

What this Trial Is About

This research investigates the prevalence and characteristics of metabolic associated fatty liver disease MAFLD in patients with type 2 diabetes mellitus T2DM in Jiangsu Province, China. It aims to understand the relationship between ultrasound attenuation parameters UAP used to assess liver fat and insulin resistance in T2DM patients. The study follows participants for up to five years to analyze clinical outcomes and risk factors related to T2DM and MAFLD progression. Participants diagnosed with T2DM according to Chinese guidelines will undergo ultrasound attenuation measurement using the iLivTouch device, along with fasting blood glucose and insulin tests. These procedures will help assess liver fat content and insulin resistance. The study includes multiple follow-up visits at 3, 6, 12, 36, 48, and 60 months to monitor participants health status over time. During the study, participants will be evaluated using ultrasound and blood tests to track liver fat and insulin resistance. Researchers will analyze the proportion of T2DM patients with MAFLD and examine how these factors relate to clinical outcomes over five years. The study aims to identify risk factors influencing disease progression, with all assessments occurring in a real-world, observational setting.

Prevalence of MAFLD in Patients With Type 2 Diabetes in Jiangsu Province of China